PORTRAYAL OF PHEOCHROMOCYTOMA AND NORMAL HUMAN ADRENAL-MEDULLA BY META-[I-123]IODOBENZYLGUANIDINE - CONCISE COMMUNICATION
- 1 January 1984
- journal article
- research article
- Vol. 25 (4) , 436-440
Abstract
The radiopharmaceutical m-[131I]iodobenzylguanidine (I-131 MIBG), which is readily taken up by adrenergic vesicles, produces scintigraphic images of pheochromocytomas in man but rarely visualizes adrenal glands. Iodine-123 has many potential advantages over I-131 as a radiolabel for MIBG, including shorter half-life, freedom from beta emissions, and increased gamma-camera efficiency. Diagnostic doses of MIBG labeled with I-131 and I-123, with nearly equivalent radiation dosimetry, were compared as imaging agents in 8 patients with known or suspected pheochromocytoma. Images of superior quality were obtained with I-123 MIBG, and lesions not visualized using I-131 MIBG were portrayed. In addition, the normal adrenal medullae were visualized on the I-123 MIBG scintigrams in 6 out of 8 patients.This publication has 6 references indexed in Scilit:
- THE NORMAL AND ABNORMAL DISTRIBUTION OF THE ADRENOMEDULLARY IMAGING AGENT M-[I-131]IODOBENZYLGUANIDINE (I-131 MIBG) IN MAN - EVALUATION BY SCINTIGRAPHY1983
- Solid-phase exchange radioiodination of aryl iodides. Facilitation by ammonium sulfateThe Journal of Organic Chemistry, 1982
- Scintigraphic Localization of PheochromocytomaNew England Journal of Medicine, 1981
- Spectrum of Pheochromocytoma in Multiple Endocrine NeoplasiaAnnals of Internal Medicine, 1981
- Suppression of Thyroid Radioiodine Uptake by Various Doses of Stable IodideNew England Journal of Medicine, 1980
- RADIOLABELED ADRENERGIC NEURON-BLOCKING AGENTS - ADRENOMEDULLARY IMAGING WITH [I-131]IODOBENZYLGUANIDINE1980